10th July 2018
US and European regulators to attend the world's first large-scale global summit dedicated to AI in healthcare
Intelligent Health, Basel, Switzerland, 12-13 September 2018
The US Food and Drug Administration (FDA) and The European Commission have confirmed attendance at the world's first large-scale global summit dedicated to AI in healthcare taking place this September in Basel, Switzerland.
The event will gather the entire global AI health ecosystem of pharmaceutical, biotech, medtech, health provision, clinicians, insurance, investment and science, some of the biggest national hospitals and health systems in Europe, the world’s largest pharmaceutical companies and the top health regulator on AI in the US.